The distinct functions of IP6K1 and IP6K2 in tumor development may also arise from their differential effects on cell proliferation, with IP6K2 knockout HCT116 cells exhibiting delayed growth [18], and IP6K1 depleted cells exhibiting no change in doubling time (Fig. 4F). The gene discussed is IP6K1; the disease is neoplasm.